Pulse Biosciences, Inc. PLSE
Set alert
53.82 USD +0.92 +1.73%
As of Nov 3, 12:40 PM ET
53.42 Day range 55.20
12.66 52-week range 55.48
- YTD
- +291.97%
- 1 year
- +220.53%
- Open
- 53.42
- Prev close
- 52.90
- Mkt cap
- 3.81B
- Vol
- 86.01K
- Avg vol
- 501.83K
- EPS
- -1.18
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 53.42
- High
- 55.20
- Forward P/E
- -45.21
- Beta
- 1.64
- Short ratio
- 5.88
- Inst. own
- 15.33%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 51.08
- 200-d avg
- 31.35
- 1y target
- 62.33
MAX chart
Events in this range
- Nov 5, 2025Earnings: -0.29; estimate -0.31; surprise 6.45%
- May 4, 2026Earnings: -0.27; estimate -0.32; surprise 15.62%
- Aug 6, 2026Earnings: -0.36; estimate -0.31; surprise -16.13%
- Oct 6, 2026Rating: Canaccord Genuity · Buy → Buy
- Nov 5, 2026Earnings: —; estimate -0.3095; surprise —%
Signals (36)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Jun 1, 2026 | 5 months ago |
| MACD: Buy Signal | Apr 1, 2026 | 7 months ago |
| SMA: Bullish | Feb 1, 2026 | 9 months ago |
| SMA: Bearish | Oct 1, 2025 | 1 year ago |
| SMA: Bullish | Sep 1, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 1, 2025 | 1 year ago |
| SMA: Bearish | Mar 1, 2025 | 1 year ago |
| SMA: Bullish | May 1, 2024 | 2 years ago |
| SMA: Bearish | Apr 1, 2024 | 2 years ago |
| SMA: Bullish | Nov 1, 2023 | 3 years ago |
| SMA: Bullish | Nov 1, 2023 | 3 years ago |
| SMA: Bearish | Sep 1, 2023 | 3 years ago |
| MACD: Buy Signal | Apr 1, 2023 | 3 years ago |
| SMA: Bullish | Dec 1, 2022 | 3 years ago |
| SMA: Bearish | Dec 1, 2021 | 4 years ago |
| MACD: Sell Signal | Dec 1, 2021 | 4 years ago |
| SMA: Bearish | Sep 1, 2021 | 5 years ago |
| SMA: Bullish | Aug 1, 2021 | 5 years ago |
| SMA: Bearish | May 1, 2021 | 5 years ago |
| RSI: Overbought | Jan 1, 2021 | 5 years ago |
Newest 20 of 36.
Analyst view
Price target (mean) 62.33 +15.8% upside
Now 53.82
- Target (low)
- 55.00
- Target (mean)
- 62.33
- Target (high)
- 73.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy1
- Buy5
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 6
- 2 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.2875 | -0.30 – -0.28 | 0.00 | 0.0% | 521.67K | +506.6% | 4 |
| Next quarter | -0.30 | -0.32 – -0.29 | -0.18003 | -66.6% | 695.00K | +163.3% | 4 |
| Current year | -1.11 | -1.13 – -1.09 | -0.7544 | -46.8% | 2.03M | +480.7% | 4 |
| Next year | -1.17 | -1.26 – -1.05 | -1.11 | -5.6% | 5.65M | +178.0% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 13, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Oct 6, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Sep 23, 2026 | BTIG | Initiated | — | Buy |
| Sep 9, 2026 | Freedom Capital Markets | Initiated | — | Buy |
| Aug 17, 2026 | Needham | Initiated | — | Buy |
| Aug 10, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Jun 4, 2026 | Canaccord Genuity | Initiated | — | Buy |
| Jul 7, 2025 | Oppenheimer | Initiated | — | Outperform |
| Sep 21, 2022 | Maxim Group | Downgrade | Buy | Hold |
| May 13, 2022 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Apr 1, 2022 | Stephens & Co. | Maintained | — | Overweight |
| Apr 1, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Feb 10, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Nov 16, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Jul 27, 2021 | Stephens & Co. | Initiated | — | Overweight |
| Mar 11, 2021 | Maxim Group | Initiated | — | Buy |
| Jan 26, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| May 12, 2020 | HC Wainwright & Co. | Upgrade | Neutral | Buy |
| Feb 14, 2020 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Feb 25, 2019 | HC Wainwright & Co. | Initiated | — | Buy |